The Current Ratio as of December 2025 (TTM) for GeneReach Biotechnology Corp. (4171.TWO) is 2.39

According to GeneReach Biotechnology Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 2.39. This represents a change of -0.25% compared to the average of 2.40 of the last 4 quarters.

GeneReach Biotechnology Corp. (4171.TWO) Historical Current Ratio (quarterly & annually)

How has 4171.TWO Current Ratio performed in the past?

The mean historical Current Ratio of GeneReach Biotechnology Corp. over the last ten years is 3.40. The current 2.39 Current Ratio has changed 6.95% with respect to the historical average. Over the past ten years (40 quarters), 4171.TWO's Current Ratio was at its highest in in the September 2023 quarter at 4.26. The Current Ratio was at its lowest in in the June 2025 quarter at 2.23.

GeneReach Biotechnology Corp. (4171.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of GeneReach Biotechnology Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GeneReach Biotechnology Corp. (4171.TWO) Average Current Ratio

How has 4171.TWO Current Ratio performed in the past?

The current Current Ratio of GeneReach Biotechnology Corp. (4171.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GeneReach Biotechnology Corp. (4171.TWO) Current Ratio vs. Peers

How is 4171.TWO’s Current Ratio compared to its peers?

GeneReach Biotechnology Corp.’s Current Ratio is less than Great Novel Therapeutics Biotech & Medicals (30.32), greater than Enimmune corporation (1.41), less than NaviFUS Corp. (15.39), less than MegaPro Biomedical Co., Ltd (4.34), less than Bio Preventive Medicine Corp. (19.06), less than BiOptic Inc. (6.27), less than LabTurbo Biotech Corporation (14.89), greater than Lukas Biomedical Inc. (1.21), greater than NeoCore Technology Co., Ltd. (1.45), less than Excelsior Biopharma Inc. (3.40),

Build a custom stock screener for GeneReach Biotechnology Corp. (4171.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneReach Biotechnology Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GeneReach Biotechnology Corp. (4171.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GeneReach Biotechnology Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.